2025-522367-15-00招募中1 期
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 53
- 试验地点
- 8
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Lilly Clinical Trials information desk
Scientific
Eli Lilly & Co.
研究点 (8)
Loading locations...
相似试验
招募中
1 期
A Phase 1 Study on the effects of LY3410738 (study drug) administered to Patients with Advanced Solid Tumors with IDH1 or IDH2 Mutations2024-515150-24-00Eli Lilly & Co.3
招募中
3 期
A real-world study on how well ribociclib and hormone therapy work together to prevent early breast cancer from coming back.CTRI/2025/08/092443Novartis Healthcare Pvt Ltd3,100
已完成
1 期
A study in people with advanced cancer to test whether the amount of BI 907828 in the blood is influenced by taking an OATP inhibitor or a CYP3 inhibitor2024-514532-24-00Boehringer Ingelheim International GmbH33
招募中
1 期
Study of GS-5319 in Adults With Solid Tumors2025-522397-36-00Gilead Sciences Inc.35
招募中
1 期
A Study of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver Impairment2025-521947-19-00Eli Lilly & Co.26